Insider trades
Jean Jacques Bienaime, Director of Keros Therapeutics KROS, has filed 20 purchases and 31 sales on the open market. Over the past 12 months that comes to a net purchase of $409.2K. The latest trade was on 06/15.
Jean Jacques Bienaime
Director
- Company
- Keros Therapeutics KROS
- First filing
- 23/01/18
- Trades
- 139 trades
- Buys / sales
- 20 / 31
- 12-month net buying
- $409.2K
- Last trade
- 06/15
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market buy10b5-1 plan | 06/15 | 06/17 | 1,000 sh | $10.19 | $10,190 | +6.0% | |
IMNM | Open-market buy | 06/05 | 06/09 | 10,500 sh3 trades | $19.45avg. | $204,260 | +31.9% |
IMNM | Open-market sale | 06/05 | 06/09 | 10,500 sh2 trades | $19.41avg. | $203,820 | −24.2% |
ASND | Open-market buy | 05/29 | 06/01 | 500 sh3 trades | $223.12avg. | $111,562 | +125.0% |
ASND | Open-market buy | 05/26 | 05/27 | 400 sh2 trades | $237.81avg. | $95,122 | No record |
ImmunomeIMNM | Open-market buy | 05/15 | 05/19 | 5,000 sh | $20.70 | $103,500 | +13.0% |
| Open-market buy10b5-1 plan | 05/15 | 05/19 | 1,000 sh | $10.58 | $10,580 | +11.8% | |
| Open-market buy10b5-1 plan | 04/15 | 04/17 | 1,000 sh | $11.70 | $11,700 | +13.4% | |
IMNM | Open-market buy | 03/10–03/11 | 03/12 | 2,000 sh2 trades | $21.84avg. | $43,670 | +5.5% |
| Open-market buy10b5-1 plan | 03/09 | 03/11 | 2,000 sh | $11.21 | $22,420 | +36.7% | |
ImmunomeIMNM | Open-market buy | 25/06/03 | 25/06/03 | 5,000 sh | $9.38 | $46,900 | +15.9% |
ImmunomeIMNM | Open-market buy | 25/03/25 | 25/03/26 | 7,800 sh | $7.78 | $60,684 | +33.0% |
ImmunomeIMNM | Open-market buy | 25/03/24 | 25/03/25 | 7,000 sh | $8.21 | $57,470 | +42.1% |
ImmunomeIMNM | Open-market buy | 24/08/16 | 24/08/19 | 7,000 sh | $13.94 | $97,580 | +72.8% |
ImmunomeIMNM | Open-market buy | 24/05/21 | 24/05/22 | 2,000 sh | $13.57 | $27,140 | +26.3% |
BMRN | Open-market sale10b5-1 plan | 24/05/09–24/05/10 | 24/05/13 | 40,000 sh2 trades | $81.38avg. | $3,255,200 | −7.8% |
BMRN | Open-market sale10b5-1 plan | 24/04/11–24/04/12 | 24/04/15 | 40,000 sh2 trades | $91.13avg. | $3,645,000 | −7.8% |
BMRN | Open-market sale | 24/03/05–24/03/06 | 24/03/07 | 2,000 sh2 trades | $86.11avg. | $172,220 | −0.4% |
| Open-market sale | 24/02/27 | 24/02/29 | 1,000 sh | $90.35 | $90,350 | −0.2% | |
BMRN | Open-market sale10b5-1 plan | 24/02/08–24/02/09 | 24/02/12 | 30,000 sh2 trades | $89.03avg. | $2,670,750 | −6.7% |
